The drug works by removing accumulated amyloid beta proteins in the brain, slowing the progress of the disease. Those ...

Acumen Pharmaceuticals, Inc. ( (ABOS) ) has released its Q3 earnings. Here is a breakdown of the information Acumen Pharmaceuticals, Inc.

The availability of amyloid-reducing therapies now makes detection of Alzheimer's disease in its early stages critical, ...

Analyst Jason Butler of JMP Securities reiterated a Buy rating on Prothena (PRTA – Research Report), retaining the price target of ...

In recent years, the focus of clinical development has been on immunotherapeutic compounds aimed at clearing brain ...

Net cash used in operating and investing activities was $45.2 million and $102.5 million for the third quarter and first nine months of 2024, respectively; quarter-end cash and restricted cash positio ...

single-injection once-monthly antibody delivered subcutaneously for the treatment of Alzheimer's disease that targets a key epitope at the N-terminus of amyloid beta (Aß) with high binding potency.

Prothena is evaluating PRX012 — a wholly owned investigational next-generation subcutaneous, single-injection once-monthly antibody delivered subcutaneously targeting a key epitope at the N-terminus ...

President and CEO: Jake Allen - Goldman Sachs: Sung Ji Nam - Scotiabank: Kyle Mikson - Canaccord Genuity: Puneet Souda - ...

Amid fears of an "extremely high level of violent protests," the Brampton Triveni Mandir and Community Centre has cancelled a Life Certificate Event.

In the 630 Battle of al-Qadisiyah, the Arab army emerged victorious and continued its march into Persia, contributing to the spread of Islam beyond West Asia.

Phuket is pulling out all the stops in a monumental bid to raise a whopping 290 million baht. The cause? Building a cutting-edge cancer care centre at Vachira Phuket Hospital. This essential ...